actinic keratoses

  • 文章类型: Journal Article
    随着我们对紫外线辐射有害影响的认识不断发展,防晒霜仍然是针对紫外线介导的多个端点的全面光防护策略的组成部分。本综述的第1部分涵盖防晒活性成分和添加剂成分特性,行动机制和覆盖面差距。在概述防晒霜预防晒伤的功效之后,光致癌作用,光老化,色素性疾病,和特发性光皮肤病,我们强调在儿童和有肤色的个人中使用和选择产品的注意事项。
    As our knowledge of the harmful effects of ultraviolet radiation continues to evolve, sunscreen remains an integral part of a comprehensive photoprotection strategy against multiple endpoints of ultraviolet-mediated damage. Part 1 of this review covers sunscreen active and additive ingredient properties, mechanisms of action and gaps in coverage. Following an overview of sunscreen\'s efficacy in protecting against sunburn, photocarcinogenesis, photoaging, pigmentary disorders, and idiopathic photodermatoses, we highlight considerations for product use and selection in children and individuals with skin of color.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    皮肤病学中常见的皮肤肿瘤涉及皮肤和附件的所有层。虽然受影响的皮肤活检仍然是确认诊断和预测肿瘤预后的重要方法,它有其局限性。最近,光动力诊断(PDD)在检测受影响的皮肤和粘膜组织方面表现出高灵敏度,为精准手术切除皮肤和粘膜肿瘤提供有价值的指导。在这次审查中,综述了PDD在光化性角化病(AK)等皮肤黏膜疾病的诊断过程和治疗中的应用,基底细胞癌(BCC),鳞状细胞癌(SCC),Bowen病(BD)和乳腺外Paget病(EMPD)。研究结果表明,PDD具有扩大临床应用的巨大前景,值得进一步研究探索。
    Skin tumors commonly seen in dermatology are involved in all layers of the skin and appendages. While biopsy of affected skin remains an essential method to confirm diagnosis and to predicate tumor prognosis, it has its limitations. Recently, photodynamic diagnosis (PDD) has demonstrated high sensitivity in detecting affected skin and mucosal tissues, providing valuable guidance for precision surgery to resect skin and mucosal tumors. In this review, we summarized the literatures concerning the applications of PDD in diagnostic process and treatment of skin and mucosal conditions such as actinic keratoses (AK), basal cell carcinoma (BCC), squamous cell carcinoma (SCC), Bowen\'s disease (BD) and extramammary Paget\'s disease (EMPD). The findings suggest that PDD holds substantial promise for expanding clinical applications and deserves further research exploration.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    研究了光谱学有助于皮肤癌诊断。的确,光谱随着癌症进展而改变,并提供补充信息(例如,在代谢和组织结构上)以临床检查为手术指导[1,2]。当前的原始数据集是由使用SpectroLive设备[3,4]在131名患者皮肤上体内采集的自发荧光和漫反射光谱组成。使用具有激发和收集光纤之间的4个距离(0.4-1mm)的多光纤探头进行空间分辨光谱测量:空间分辨率允许在不同距离处获取的光谱携带来自皮肤组织中不同深度的信息。使用五种不同波长激发(在365-415nm光谱范围内)采集了五种类型的自发荧光光谱,以收集有关几种皮肤内源性荧光团的信息(例如,黄素,胶原蛋白)。第六光源(白色宽带)用于获取携带关于皮肤散射性质和皮肤内源性吸收剂(例如黑色素和血红蛋白)的信息的漫反射光谱。如果患者被怀疑患有光化性角化病(癌前皮肤病变)或基底或鳞状细胞癌,则建议将其纳入临床试验:在所有情况下,数据集中提供完整的诊断。为了增加数据集的兴趣并评估光谱的依赖性(强度,形状)不仅在病理状态上,而且在健康的皮肤特征上(民用年龄,皮肤年龄,性别,照型,解剖部位),光谱是在两个所谓的“参考”皮肤部位获得的,已知很少患有皮肤癌:手掌(具有厚皮肤类型)和内手腕(具有薄皮肤)。光谱可在。选项卡文件:第一列显示记录强度光谱的光谱范围(317-788nm),并且下一列中的每一列提供由每个光谱仪针对光源激发和距离的给定组合获得的强度光谱。与131名患者中的每一个对应的131个文件夹中的每一个包含a.JSON文件提供患者临床特征:性别,民事年龄,皮肤年龄,照型分数和类别。全部。选项卡文件名包括采集光谱的皮肤部位的解剖部位和解剖病理学诊断:定义代码以匹配字母或缩写到每个诊断和解剖部位。为了确保质量控制,在开始对每位患者进行光谱采集之前,在相同的校准标准品上采集光谱。因此,可以跟踪在包括患者的4.5年期间采集光链老化的影响。流行病学家可以使用此数据集来表征受皮肤癌影响的人群(性别比例,平均年龄,通常受影响的解剖部位,等。);人工智能领域的研究人员也可能使用它来开发创新的方法来处理此类数据,并有助于对发病率稳步上升的皮肤癌进行非侵入性诊断。
    Optical spectroscopy is studied to contribute to skin cancer diagnosis. Indeed, optical spectra are modified along cancer progression and provide complementary information (e.g., on metabolism and tissue structure) to clinical examination for surgical guidance [1,2]. The current original dataset is made of autofluorescence and diffuse reflectance spectra acquired in vivo on 131 patients\' skin with the SpectroLive device [3,4]. Spatially-resolved spectroscopy measurements were performed using a multi-fiber optic probe featuring 4 distances (0.4-1 mm) between excitation and collection optical fibers: spatial resolution allows spectra acquired at different distances to carry information from different depths in skin tissues. Five types of autofluorescence spectra were acquired using five different wavelength excitations (on the 365-415 nm spectral range) in order to collect information on several skin endogenous fluorophores (e.g., flavins, collagen). A sixth light source (white broadband) was used to acquire diffuse reflectance spectra carrying information about skin scattering properties and skin endogenous absorbers such as melanin and hemoglobin. Patients were proposed to be included into the clinical trial if they were suspected of suffering from actinic keratoses (precancerous skin lesions) or from basal or squamous cell carcinomas: in all cases, complete diagnostics is provided in the dataset. To increase the interest of the dataset and evaluate the dependence of optical spectra (intensity, shape) not only on pathological states but also on healthy skin features (civil age, skin age, gender, phototype, anatomical site), spectra were acquired for all 131 patients on two so-called \"reference\" skin sites known to rarely suffer from skin cancer: palm of the hand (featuring a thick skin type) and inner wrist (featuring thin skin). Spectra are available in .tab files: first column displays the spectral range on which intensity spectra were recorded (317-788 nm) and each following column provides an intensity spectrum acquired by each spectrometer for a given combination of light source excitation and distance. Each of the 131 folders corresponding to each of the 131 patients contains a .json file providing patients clinical features: gender, civil age, skin age, phototype score and class. All .tab files names include anatomical site and anatomopathological diagnostics of the skin site on which spectra were acquired: codes were defined to match a letter or an acronym to each diagnostic and anatomical site. To ensure quality control, a spectrum was acquired on the same calibration standard before starting spectra acquisition on each patient. It is therefore possible to follow the impact of the acquisition optical chain ageing during the 4.5 years that the patients were included. This dataset can be used by epidemiologists for the characterization of populations affected by skin cancers (gender ratio, mean age, anatomical sites typically affected, etc.); it may also be used by researchers in artificial intelligence to develop innovative methods to process such data and contribute to non-invasive diagnostics of skin cancers whose incidence is steadily increasing.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Letter
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Review
    本文回顾了2022年欧洲光动力治疗学会(Euro-PDT)年度大会。PDT已经被研究用于治疗多种肿瘤,感染和炎症指征。新的研究证实了广泛使用局部PDT治疗痤疮和光老化的潜力,以及几种罕见的疾病,包括头癣,marinum分枝杆菌,皮肤交替病,抗性肢端疣,眼睑Bowen病,霉菌病,假性淋巴瘤,和移植物抗宿主病。化脓性汗腺炎患者也可从病灶内PDT获益。已经验证了几种提供PDT的方法,包括常规的,日光和人工日光PDT。发光织物已成为一种创新的解决方案,可以在头皮以及具有解剖学挑战性的部位上提供均匀的光。现在有机会通过手机应用程序控制和监控这些设备。患者的治疗前较厚,骨化三醇治疗光化性角化病(AK)似乎是一种提高疗效的实用方法,尽管这与局部皮肤反应增加有关。用日光-PDT和可注射NASHA凝胶对AK和光老化的顺序治疗表明这两种治疗方法提供了互补的效果。潜在的生物标志物可能有助于预测接受日光PDT的田野癌变和AK患者的反应性。原癌基因的过度表达,Myc,在反应不佳的人中观察到,而肿瘤抑制基因,PTEN,显示表达不足。用于皮肤病学适应症的局部PDT的使用和递送方法的潜力继续扩大提供给患者的治疗的增强选择。
    This article reviews the 2022 European Society for Photodynamic Therapy (Euro-PDT) Annual Congress. PDT has been investigated for the treatment of a broad number of oncologic, infectious and inflammatory indications. New studies confirm the potential for wider use of topical PDT for acne and photoaging, as well as several uncommon conditions including tinea capitis, Mycobacterium marinum, cutaneous alternariosis, resistant acral warts, eyelid Bowen\'s disease, mycosis fungoides, pseudolymphoma, and graft-versus-host disease. Hidradenitis suppurativa patients may also benefit from intra-lesional PDT. Several methods of delivering PDT have been validated, including conventional, daylight and artificial daylight PDT. Light-emitting fabrics have emerged as an innovative solution to the delivery of uniform light over the scalp as well as anatomically-challenging sites, with opportunities now to control and monitor these devices via mobile phone applications. Pre-treatment of patients with thicker, more difficult-to-treat actinic keratoses (AK) with calcitriol appears to be a practical approach to increasing efficacy, although this is associated with increased local skin reactions. Sequential treatment of AK and photoaging with daylight-PDT and injectable NASHA gel indicates that these two therapeutic approaches offer complementary effects. Potential biomarkers may help predict responsiveness of patients with field cancerization and AK receiving daylight PDT. Over-expression of the proto-oncogene, Myc, has been observed in poor responders, whilst the tumour suppressor gene, PTEN, showed under-expression. The potential for use and methods of delivery of topical PDT for dermatological indications continue to expand the enhanced choice of treatment offered to patients.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Meta-Analysis
    背景:烟酰胺是通过内源性合成获得的维生素B3(烟酸)的活性形式,主要通过色氨酸代谢和膳食补充剂,鱼,肉类,谷物,和乳制品。它参与细胞能量代谢并调节多种细胞存活和死亡途径。烟酰胺已被广泛研究作为减少光化性角化病(AKs)和非黑素瘤皮肤癌(NMSC)的安全化学预防剂。
    方法:我们使用了Medline,EMBASE,PubMed,和Cochrane数据库搜索“烟酰胺”的概念,“化学预防”,和“皮肤癌”到2023年8月。在搜索全文以获取资格标准之前,三名独立作者筛选了标题和摘要以进行干预和研究设计。主要结果是口服烟酰胺对高危患者NMSC发生率的影响。我们还进行了系统的搜索,以确定已发表的评估膳食烟酸摄入量和NMSC风险的相关流行病学研究。
    结果:回顾了二百二十五项研究,四人符合纳入标准。NAM消费与鳞状细胞癌(SCC)风险之间没有关联(比率(RR)0.81,95%CI0.48-1.37;I2=0%),基底细胞癌(BCC)(RR0.88,95%CI0.50-1.55;I2=63%),和NMSC(RR0.82,95%CI0.61-1.12;I2=63%)。不良事件罕见且可接受,允许患者对治疗的最佳依从性。我们发现只有一篇文章评估烟酸饮食摄入量与NMSC风险之间的关系,支持烟酸摄入对SCC而不是BCC或黑色素瘤的潜在有益作用。
    结论:本荟萃分析显示,通过汇集有免疫能力和免疫抑制的患者,没有足够的证据表明口服烟酰胺治疗显著减少角质形成细胞癌的数量。
    BACKGROUND: Nicotinamide is the active form of vitamin B3 (niacin) obtained through endogenous synthesis, mainly through tryptophan metabolism and dietary supplements, fish, meats, grains, and dairy products. It participates in cellular energy metabolism and modulates multiple cellular survival and death pathways. Nicotinamide has been widely studied as a safe chemopreventive agent that reduces actinic keratosis (AKs) and non-melanoma skin cancers (NMSC).
    METHODS: We used the Medline, EMBASE, PubMed, and Cochrane databases to search the concepts \"nicotinamide\", \"chemoprevention\", and \"skin cancer\" up to August 2023. Three independent authors screened titles and abstracts for intervention and study design before searching full texts for eligibility criteria. The primary outcome was the impact of oral nicotinamide on the incidence of NMSC in high-risk patients. We also conducted a systematic search to identify relevant epidemiological studies published evaluating dietary niacin intake and the risk of NMSC.
    RESULTS: Two hundred and twenty-five studies were reviewed, and four met the inclusion criteria. There was no association between NAM consumption and risk for squamous cell carcinoma (SCC) (rate ratio (RR) 0.81, 95% CI 0.48-1.37; I2 = 0%), basal cell carcinoma (BCC) (RR 0.88, 95% CI 0.50-1.55; I2 = 63%), and NMSC (RR 0.82, 95% CI 0.61-1.12; I2 = 63%). Adverse events were rare and acceptable, allowing optimal compliance of patients to the treatment. We found only one article evaluating the association between niacin dietary intake and NMSC risk, supporting a potential beneficial role of niacin intake concerning SCC but not BCC or melanoma.
    CONCLUSIONS: The present meta-analysis shows, by pooling immunocompetent and immunosuppressed patients, that there is insufficient evidence that oral nicotinamide therapy significantly reduces the number of keratinocyte cancers.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    简介:光动力疗法(PDT)是一种光和光活化化学物质的组合方法,称为光敏剂(PS)。建议将PDT作为一种高治愈率的方法,副作用少,并且是治疗癌症的非侵入性工具。本研究旨在通过使用基因表达综合(GEO)的基因表达谱,通过蛋白质-蛋白质相互作用(PPI)网络分析,评估PDT作为治疗光化性角化病的方法。方法:从GEO中提取21个基因表达谱,并通过GEO2R进行分析,以确定显着的差异表达基因(DEGs)。通过Cytoscape软件将重要的DEG包含在PPI网络中。网络由“网络分析仪”分析并对主要连接组件的元素进行了评估。结果:比较组的基因表达谱有三个主要的相关成分,包括PDT与健康(健康组)皮肤之前(之前)和之后(之后)的皮肤病变区域。健康前比较显示与健康后评估部分相似。前后评估表明,PDT前后病变区域的基因表达谱之间没有显着差异。结论:总之,PDT无法使光化性角化病皮肤的基因表达模式完全恢复到健康状态。
    Introduction: Photodynamic therapy (PDT) is a combined method of light and light-activated chemicals that are called photosensitizers (PSs). PDT is recommended as a high cure rate method with fewer side effects and a noninvasive tool to treat cancer. This study aimed to evaluate PDT efficacy as a therapeutic method against actinic keratoses in patients via protein-protein interaction (PPI) network analysis by using the gene expression profiles of Gene Expression Omnibus (GEO). Methods: Twenty-one gene expression profiles were extracted from GEO and analyzed by GEO2R to determine the significant differentially expressed genes (DEGs). The significant DEGs were included in PPI networks via Cytoscape software. The networks were analyzed by the \"Network Analyzer\", and the elements of the main connected components were assessed. Results: There were three main connected components for the compared sets of the gene expression profiles including the lesional region of skin before (Before set) and after (After set) PDT versus healthy (healthy set) skin and before versus after. The before-health comparison showed a partial similarity with the After-Healthy assessment. The before-after evaluation indicated that there were not considerable differences between the gene expression profile of the lesional region before and after PDT. Conclusion: In conclusion, PDT was unable to return the gene expression pattern of the actinic keratoses skin to a healthy condition completely.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • DOI:
    文章类型: Journal Article
    光化性角化病(AK)是癌前病变,发育不良,由慢性阳光照射引起的表皮病变可能进展为鳞状细胞癌。采用蓝光光动力疗法(ALA-PDT)的氨基乙酰丙酸20%溶液先前已被证明优于载体加PDT(VEH-PDT)治疗面部AKs,头皮,和上肢。
    我们报告了ALA-PDT的详细患者满意度数据。
    患者对ALA-PDT与VEH-PDT的满意度以及患者报告的ALA-PDT与先前AKs治疗的可接受性进行了三个随机评估,成人车辆对照研究(两个II期和一个III期)。II期研究中的患者在头皮和/或面部接受治疗,III期研究中的患者在上肢接受了治疗。
    共有234、166和269名患者参加了两项II期研究和一项III期研究,分别;总的来说,79.8%的患者为男性。ALA-PDT的总体治疗满意度为79%至88%,相比之下,VEH-PDT为35%至56%。患者通常认为ALA-PDT与以前的治疗相当或更可接受。包括冷冻疗法,5-氟尿嘧啶,咪喹莫特,以前的PDT,和手术。上肢接受ALA-PDT或VEH-PDT的患者比例相似,副作用/不良事件(AE),和副作用/AE的持续时间是可接受的。
    大多数患者是男性,没有进行统计学比较。
    患者普遍对ALA-PDT治疗面部AKs感到满意,头皮,和上肢,并认为ALA-PDT等于或比以前的治疗更可接受。
    ClinicalTrials.gov:NCT01475955;NCT02239679;NCT02137785。
    UNASSIGNED: Actinic keratoses (AKs) are precancerous, dysplastic, epidermal lesions caused by chronic sun exposure that may progress to squamous cell carcinoma. Aminolevulinic acid 20% solution with blue light photodynamic therapy (ALA-PDT) has previously been shown to be superior to vehicle plus PDT (VEH-PDT) for treatment of AKs of the face, scalp, and upper extremities.
    UNASSIGNED: We report detailed patient satisfaction data for ALA-PDT.
    UNASSIGNED: Patient satisfaction for ALA-PDT versus VEH-PDT and patient-reported acceptability of ALA-PDT versus previous treatments for AKs were assessed in three randomized, vehicle-controlled studies (two Phase II and one Phase III) in adults. Patients in the Phase II studies were treated on the scalp and/or face, and those in the Phase III study were treated on the upper extremities.
    UNASSIGNED: A total of 234, 166, and 269 patients were enrolled in the two Phase II studies and one Phase III study, respectively; overall, 79.8 percent of patients were male. Overall treatment satisfaction ranged from 79 to 88 percent for ALA-PDT, compared to 35 to 56 percent for VEH-PDT. Patients generally considered ALA-PDT to be equivalent to or more acceptable than prior treatments, including cryotherapy, 5-fluorouracil, imiquimod, previous PDT, and surgery. Similar proportions of patients receiving ALA-PDT or VEH-PDT on the upper extremities considered in-office time, side effects/adverse events (AEs), and duration of side effects/AEs to be acceptable.
    UNASSIGNED: The majority of patients were male, and no statistical comparisons were conducted.
    UNASSIGNED: Patients were generally satisfied with ALA-PDT for the treatment of AKs of the face, scalp, and upper extremities and considered ALA-PDT to be equal to or more acceptable than previous treatments.
    UNASSIGNED: ClinicalTrials.gov: NCT01475955; NCT02239679; NCT02137785.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    Mit Hilfe des histologischen PRO-Scores (I-III) kann das Risiko einer malignen Transformation aktinischer Keratosen (AK) abgeschätzt werden, indem er das Ausmaß der Undulation und basalen Proliferation der dermoepidermalen Junktionszone (DEJ) bewertet. Die konfokale Line-Field optische Kohärenztomographie (LC-OCT) ermöglicht eine nichtinvasive Bestimmung des PRO-Scores in Echtzeit. Anhand von LC-OCT-Bilddatensätzen kann eine künstliche Intelligenz (KI) mit Hilfe von Convolutional Neural Networks (CNN) zur automatischen Quantifizierung des PRO-Scores von AK in vivo trainiert werden.
    Convolutional Neural Networks wurden trainiert, um LC-OCT-Bilder von gesunder Haut und von AK zu segmentieren. PRO-Score-Modelle wurden in Übereinstimmung mit dem histopathologischen Goldstandard entwickelt und an einer Teilmenge von 237 LC-OCT-AK-Bildern trainiert und an 76 Bildern getestet, wobei der von der KI-berechnete PRO-Score mit dem visuellen Konsens der Bildgebungsexperten verglichen wurde.
    Eine signifikante Übereinstimmung wurde in 57/76 (75%) Fällen festgestellt. Die KI-basierte Bewertung des PRO-Scores korrelierte am besten mit dem visuellen Score für PRO II (84,8%) vs. PRO III (69,2%) vs. PRO I (66,6%). In 25% der Fälle kam es zu Fehlinterpretationen, die meist auf eine Verschattung der DEJ sowie störende Merkmale wie Haarfollikel zurückzuführen waren.
    Die Ergebnisse deuten darauf hin, dass CNN für die automatische Quantifizierung des PRO-Scores in LC-OCT-Bilddatensätzen hilfreich sind. Dies könnte zur nichtinvasiven Bewertung des Proliferationsrisikos in der Diagnostik und Nachsorge von AK herangezogen werden.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:组织学PRO评分(I-III)有助于通过对真皮-表皮连接(DEJ)起伏进行分级来评估光化性角化病(AK)的恶性潜能。线场共聚焦光学相干断层扫描(LC-OCT)提供非侵入性实时PRO评分量化。根据LC-OCT成像数据,人工智能(AI)的训练,使用卷积神经网络(CNN)可以实现体内AK的自动化PRO评分量化。
    方法:训练CNN分割健康皮肤和AK的LC-OCT图像。根据组织病理学黄金标准开发PRO评分模型,并在237张LC-OCTAK图像的子集上进行训练,并在76张图像上进行测试。将AI计算的PRO评分与成像专家的视觉共识进行比较。
    结果:在57/76例(75%)中发现了显着的一致性。AI自动评分与PROII的视觉评分(84.8%)和PROIII(69.2%)与PROI(66.6%)。25%的病例发生误解,主要是由于DEJ的阴影和毛囊等破坏性特征。
    结论:研究结果表明,CNN有助于LC-OCT图像中PRO评分的自动化量化。这可以为临床医生在AK的随访中提供用于PRO评分评估的可行工具。
    The histological PRO score (I-III) helps to assess the malignant potential of actinic keratoses (AK) by grading the dermal-epidermal junction (DEJ) undulation. Line-field confocal optical coherence tomography (LC-OCT) provides non-invasive real-time PRO score quantification. From LC-OCT imaging data, training of an artificial intelligence (AI), using Convolutional Neural Networks (CNNs) for automated PRO score quantification of AK in vivo may be achieved.
    CNNs were trained to segment LC-OCT images of healthy skin and AK. PRO score models were developed in accordance with the histopathological gold standard and trained on a subset of 237 LC-OCT AK images and tested on 76 images, comparing AI-computed PRO score to the imaging experts\' visual consensus.
    Significant agreement was found in 57/76 (75%) cases. AI-automated grading correlated best with the visual score for PRO II (84.8%) vs. PRO III (69.2%) vs. PRO I (66.6%). Misinterpretation occurred in 25% of the cases mostly due to shadowing of the DEJ and disruptive features such as hair follicles.
    The findings suggest that CNNs are helpful for automated PRO score quantification in LC-OCT images. This may provide the clinician with a feasible tool for PRO score assessment in the follow-up of AK.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号